As states file new generic drug complaint, time is running out for DOJ

By Leah Nylen and Max Fillion (May 21, 2019) -- Forty-three states released a shocking new antitrust complaint detailing how major drug companies including Teva, Sandoz, Mylan, Pfizer and others allegedly fixed prices on hundreds of generic drugs. The states’ investigation of generic drug manufacturers has been ongoing since 2014, alongside a criminal antitrust probe by federal prosecutors....

Related Sections